PharmaVoice 100


  • Image attribution tooltip
    [photo]. Retrieved from Ovid Therapeutics.
    Q&A

    Ovid's CEO shares his vision for rare disease developments

    Jeremy Levin, chairman and CEO of Ovid Therapeutics discusses the keys to success in rare disease innovation.

    By Kim Ribbink • Jan. 10, 2022
  • Image attribution tooltip
    Justin Sullivan/ via Getty Images
    Q&A

    How the executive VP of HR at Incyte is tackling pharma's hiring woes

    In an industry undergoing rapid growth, the increasing job opening rates and limited talent pool are taking on a new level of importance.

    By Jan. 10, 2022
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Profile

    PharmaVoice 100 Who's on the List – By Category

    Who’s on the List — 2021 Indexed by Category Commanders & Chiefs Dr. Sam Agresta Foghorn Therapeutics Alisha Alaimo Biogen Shideh Bina Insigniam Dr. Norbert Bischofberger Kronos Bio Dr. James Kyle Bryan IQVIA Biotech Victor Bultó Novartis Pharmaceuticals Dr. Tony ...

    By PharmaVoice Team • Aug. 1, 2021
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Profile

    Commanders & Chiefs

    These forward-thinking leaders are inspiring their teams to achieve far-reaching goals and strategically positioning their companies for success as they navigate complex industry challenges. Be bold Igniting change by… Addressing barriers between patients and their medicines Vict...

    By PharmaVoice Team • Aug. 1, 2021